Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.
- Published In:
- International journal of obesity (2005), 49(10), 1946-1957 (2025)
- Authors:
- Ismaiel, Abdulrahman, Scarlata, Giuseppe Guido Maria, Boitos, Irina, Leucuta, Daniel-Corneliu, Popa, Stefan-Lucian, Al Srouji, Nahlah, Abenavoli, Ludovico, Dumitrascu, Dan L
- Database ID:
- RPEP-11535
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11535APA
Ismaiel, Abdulrahman; Scarlata, Giuseppe Guido Maria; Boitos, Irina; Leucuta, Daniel-Corneliu; Popa, Stefan-Lucian; Al Srouji, Nahlah; Abenavoli, Ludovico; Dumitrascu, Dan L. (2025). Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.. International journal of obesity (2005), 49(10), 1946-1957. https://doi.org/10.1038/s41366-025-01859-6
MLA
Ismaiel, Abdulrahman, et al. "Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.." International journal of obesity (2005), 2025. https://doi.org/10.1038/s41366-025-01859-6
RethinkPeptides
RethinkPeptides Research Database. "Gastrointestinal adverse events associated with GLP-1 RA in ..." RPEP-11535. Retrieved from https://rethinkpeptides.com/research/ismaiel-2025-gastrointestinal-adverse-events-associated
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.